What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models
- PMID: 28348037
- PMCID: PMC5880169
- DOI: 10.1101/cshperspect.a031583
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models
Abstract
Animal models are an essential feature of the vaccine design toolkit. Although animal models have been invaluable in delineating the mechanisms of immune function, their precision in predicting how well specific vaccines work in humans is often suboptimal. There are, of course, many obvious species differences that may limit animal models from predicting all details of how a vaccine works in humans. However, careful consideration of which animal models may have limitations should also allow more accurate interpretations of animal model data and more accurate predictions of what is to be expected in clinical trials. In this article, we examine some of the considerations that might be relevant to cross-species extrapolation of vaccine-related immune responses for the prediction of how vaccines will perform in humans.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.
Figures

Similar articles
-
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection.Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a028902. doi: 10.1101/cshperspect.a028902. Cold Spring Harb Perspect Biol. 2018. PMID: 28348035 Free PMC article. Review.
-
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive.Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a029504. doi: 10.1101/cshperspect.a029504. Cold Spring Harb Perspect Biol. 2018. PMID: 28348034 Free PMC article. Review.
-
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Reevaluating the Potential of Mouse Models for the Human Immune System.Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a029132. doi: 10.1101/cshperspect.a029132. Cold Spring Harb Perspect Biol. 2018. PMID: 28348039 Free PMC article. Review.
-
Use of animal models in the development of human vaccines.Future Microbiol. 2007 Dec;2(6):667-75. doi: 10.2217/17460913.2.6.667. Future Microbiol. 2007. PMID: 18041907 Review.
-
A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery.Adv Drug Deliv Rev. 2002 Oct 4;54(6):851-61. doi: 10.1016/s0169-409x(02)00072-8. Adv Drug Deliv Rev. 2002. PMID: 12363434 Review.
Cited by
-
Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response.Biomicrofluidics. 2021 Mar 23;15(2):021501. doi: 10.1063/5.0038924. eCollection 2021 Mar. Biomicrofluidics. 2021. PMID: 33791050 Free PMC article. Review.
-
Towards COVID-19 Prophylaxis: An AIDS Preclinical Research Perspective.Cancer Stud Ther. 2020 Jul;5(2):https://researchopenworld.com/towards-covid-19-prophylaxis-an-aids-preclinical-research-perspective/. Epub 2020 Jul 19. Cancer Stud Ther. 2020. PMID: 32905553 Free PMC article.
-
The Promises of Speeding Up: Changes in Requirements for Animal Studies and Alternatives during COVID-19 Vaccine Approval-A Case Study.Animals (Basel). 2022 Jul 5;12(13):1735. doi: 10.3390/ani12131735. Animals (Basel). 2022. PMID: 35804634 Free PMC article.
-
Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem.Front Pharmacol. 2024 Dec 17;15:1499079. doi: 10.3389/fphar.2024.1499079. eCollection 2024. Front Pharmacol. 2024. PMID: 39741624 Free PMC article.
-
How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays.Vaccines (Basel). 2024 May 28;12(6):586. doi: 10.3390/vaccines12060586. Vaccines (Basel). 2024. PMID: 38932315 Free PMC article. Review.
References
-
- Barton ES, White DW, Cathelyn JS, Brett-McClellan K, Engle M, Diamond MS, Miller VL, Virgin HW. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447: 326–329. - PubMed
-
- Beran J, Wertzova V, Honegr K, Kaliskova E, Havlickova M, Havlik J, Jirincova H, Van Belle P, Jain V, Innis B, et al. 2009. Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: A concrete example. BMC Infect Dis 9: 2. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical